Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.19 | 9.28 |
| PEG Ratio (TTM) | -1.25 | -0.64 |
| P/S Ratio (TTM) | 0.64 | 0.86 |
| P/B Ratio (TTM) | 1.25 | 1.10 |
| P/FCF Ratio (TTM) | 1.54 | 4.29 |
| Price to 5YR AVG Earnings Ratio | 2.41 | 10.79 |
| Price to 5YR AVG FCF Ratio | 4.58 | 5.33 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.61% | 3.70% |
| ROE (TTM) | 7.38% | 19.66% |
| Net Profit Margin (TTM) | 3.32% | 15.57% |
| ROIC 5YR AVG | 3.61% | 9.05% |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -9.71% | 4.18% | 14.27% |
| Revenue | 3.94% | 9.09% | 7.53% |
| Net Income | -9.63% | 5.97% | 15.23% |
| Cash Flow | 79.42% | 38.60% | 49.81% |
Health (72%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 17.33 | 8.41 |
| Quick Ratio (TTM) | 17.33 | 7.57 |
| D/E Ratio (TTM) | 0.46 | 0.33 |
| Interest Coverage (TTM) | 3.40 | 23.87 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 1.18 | 0.99 |
| LTL to 5YR AVG FCF | 1.47 | 1.75 |
| Shares Outstanding Growth 5YR AVG | 1.08% | 729.68% |